English
  1. Home
  2. Stocks
  3. Fredun Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Fredun Pharmaceuticals Share Price Fredun Pharmaceuticals

    Small Cap
    ₹812.65
    -41.5 (-4.86%)
    14 May, 2024 01:28 BSE: 539730 NSE: FREDUNISIN: INE194R01017

    Start SIP in Fredun Pharmaceuticals

    Start SIP

    Fredun Pharmaceuticals Performance

    Day Range

    • Low 0
    • High 0
    ₹ 812

    52 Week Range

    • Low 0
    • High 0
    ₹ 812
    • Open Price0
    • Previous Close0
    • Volume

    Fredun Pharmaceuticals Share Price

    • Over 1 Month +3.8%
    • Over 3 Month -0.02%
    • Over 6 Month -6.2%
    • Over 1 Year -12.96%

    Fredun Pharmaceuticals Key Statistics

    Fredun Pharmaceuticals Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 11787816180
    Operating Expenses Qtr Cr 10776725468
    Operating Profit Qtr Cr 11109712
    Depreciation Qtr Cr 11111
    Interest Qtr Cr 44334
    Tax Qtr Cr 12224
    Net Profit Qtr Cr 54424
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 349276
    Operating Expenses Annual Cr 310247
    Operating Profit Annual in Cr 3928
    Depreciation Cr 43
    Interest Annual Cr 149
    Tax Annual Cr 67
    Net Profit Annual Cr 1611
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 0-14
    Cash from Investing Activity Annual Cr -8-9
    Cash from Financing Annual Activity Cr 625
    Net Cash Flow Annual Cr 1
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 12196
    Fixed Assets Annual Cr 4739
    Total Non Current Assets Annual Cr 5041
    Total Current Assets Annual Cr 257216
    Total Assets Annual Cr 308257
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 258213
    ROE Annual % 1311
    ROCE Annual % 2618
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1111
    Sign Up to Know More
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Sign Up to Know More
    Invest in Fredun Pharmaceuticals

    Fredun Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹812.65
    -41.5 (-4.86%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹862.38
    • 50 Day
    • ₹840.13
    • 100 Day
    • ₹843.04
    • 200 Day
    • ₹864.27
    • 20 Day
    • ₹853.94
    • 50 Day
    • ₹816.53
    • 100 Day
    • ₹839.04
    • 200 Day
    • ₹878.75

    Fredun Pharmaceuticals Resistance and Support

    PIVOT
    ₹826.52
    Resistance
    First Resistance 851.03
    Second Resistance 889.42
    Third Resistance 913.93
    RSI 45.33
    MFI 71.35
    MACD Single Line 27.13
    MACD 19.96
    Support
    First Resistance 788.13
    Second Resistance 763.62
    Third Resistance 725.23

    Fredun Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 10,571 694,726 65.72
    Week 20,567 1,420,535 69.07
    1 Month 16,041 1,148,570 71.6
    6 Month 9,559 718,421 75.16

    Fredun Pharmaceuticals Result Highlights

    Fredun Pharmaceuticals Synopsis

    BSE-Medical-Diversified

    Fredun Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 274.68 Cr. and Equity Capital is Rs. 4.53 Cr. for the Year ended 31/03/2023. Fredun Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 08/06/1987 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1987PLC043662 and registration number is 043662.
    Market Cap 379
    Sales 347
    Shares in Float 0.24
    No of funds 1
    Yield 0.08
    Book Value 3.14
    U/D Vol ratio 1
    LTDebt / Equity 4
    Alpha -0.14
    Beta 1.27

    Fredun Pharmaceuticals

    Owner NameApr-24Mar-24Dec-23Sep-23
    Promoters 48.92%49.17%49.16%49.31%
    Financial Institutions/ Banks 1.59%1.6%1.6%1.6%
    Individual Investors 43.94%44.02%43.67%43.48%
    Others 5.55%5.21%5.57%5.61%

    Fredun Pharmaceuticals Management

    Name Designation
    Dr.(Mrs.) Daulat N Medhora Chairman & Jt. M. D
    Mr. Fredun Medhora Managing Director & CFO
    Mr. Nariman Medhora Non Executive Director
    Dr. Aspi Raimalwala Ind. Non-Executive Director
    Dr. Rohinton Kanga Ind. Non-Executive Director

    Fredun Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Fredun Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-05-07 Audited Results & Final Dividend
    2024-02-14 Quarterly Results
    2023-12-16 Others Rs.0.00 alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method.
    2023-11-08 Quarterly Results
    2023-07-19 Quarterly Results
    Date Purpose Remarks
    2023-09-22 FINAL Rs.0.70 per share(7%)Final Dividend

    Fredun Pharmaceuticals MF Shareholding

    Name Amount(cr)

    Fredun Pharmaceuticals FAQs

    What is Share Price of Fredun Pharmaceuticals ?

    Fredun Pharmaceuticals share price is ₹812 As on 14 May, 2024 | 01:14

    What is the Market Cap of Fredun Pharmaceuticals ?

    The Market Cap of Fredun Pharmaceuticals is ₹379 Cr As on 14 May, 2024 | 01:14

    What is the P/E ratio of Fredun Pharmaceuticals ?

    The P/E ratio of Fredun Pharmaceuticals is 24.3 As on 14 May, 2024 | 01:14

    What is the PB ratio of Fredun Pharmaceuticals ?

    The PB ratio of Fredun Pharmaceuticals is 3.1 As on 14 May, 2024 | 01:14

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.